Assignee
RIPPLE THERAPEUTICS CORP
CA9 patents
Top patents by PatentIndex Score
US10959954B2Mar 30, 2021
Dexamethasone prodrug compositions and uses thereof
RIPPLE THERAPEUTICS CORP3 citations81
US10945958B2Mar 16, 2021
Dexamethasone prodrug compositions and uses thereof
RIPPLE THERAPEUTICS CORP3 citations80
US10632075B2Apr 28, 2020
Glass formulations and uses thereof
RIPPLE THERAPEUTICS CORP4 citations80
US10588862B2Mar 17, 2020
Dexamethasone prodrug compositions and uses thereof
RIPPLE THERAPEUTICS CORP5 citations80
US11612567B2Mar 28, 2023
Ocular inserts comprising a covalently linked steroid dimer
RIPPLE THERAPEUTICS CORP0 citations59
US12509469B2Dec 30, 2025
Compositions and methods for the treatment of pain and dependence disorders
RIPPLE THERAPEUTICS CORP0 citations55
US11279729B2Mar 22, 2022
Heterodimer compositions and methods for the treatment of ocular disorders
RIPPLE THERAPEUTICS CORP1 citations55
US12473326B2Nov 18, 2025
Crystalline forms of dexamethasone dimers and uses thereof
RIPPLE THERAPEUTICS CORP0 citations52
US11464914B2Oct 11, 2022
Intravitreal injector
RIPPLE THERAPEUTICS CORP0 citations41